Development and validation of the competing risk nomogram and risk classification system for predicting cancer-specific mortality in patients with cervical adenosquamous carcinoma treated via radical hysterectomy.

[ 11 ] reported a significant trend favoring radical hysterectomy over radio-chemotherapy for IB1-IIA2 cervical cancer, evidencing improved OS (84.6% vs 76.1%, P < 0.001) and disease-free survival (DFS) (81.5% vs 75.1%, P < 0.001).

also in 9,775 other papers

Cervical adenosquamous carcinoma (ASC), a rare histological subtype of cervical cancer that accounts for only 3%–10% of all cervical malignancies, has shown an increasing trend over the years, particularly among postmenopausal women [ 4 , 5 ].

also in 63,971 other papers